Mortality

Wilkinson, T. J., Miksza, J., Zaccardi, F., Lawson, C., Nixon, A. C., Young, H. M. L., et al. (2022). Associations between frailty trajectories and cardiovascular, renal, and mortality outcomes in chronic kidney disease. J Cachexia Sarcopenia Muscle. http://doi.org/10.1002/jcsm.13047
Impara, E., Bakolis, I., Bécares, L., Dasch, H., Dregan, A., Dyer, J., et al. (2022). COVID-19 ethnic inequalities in mental health and multimorbidities: protocol for the COVEIMM study. Soc Psychiatry Psychiatr Epidemiol, 1-11. http://doi.org/10.1007/s00127-022-02305-y
Dashtban, A., Mizani, M. A., Denaxas, S., Nitsch, D., Quint, J., Corbett, R., et al. (2022). A retrospective cohort study measured predicting and validating the impact of the COVID-19 pandemic in individuals with chronic kidney disease. Kidney Int. http://doi.org/10.1016/j.kint.2022.05.015
Chung, S. C., Providencia, R., Sofat, R., Pujades-Rodriguez, M., Torralbo, A., Fatemifar, G., et al. (2022). Incidence, morbidity, mortality and disparities in dementia: A population linked electronic health records study of 4.3 million individuals. Alzheimers Dement. http://doi.org/10.1002/alz.12635
Gulliford, M. C., Prevost, A. T., Clegg, A., & Rezel-Potts, E. (2022). Mortality of Care Home Residents and Community-Dwelling Controls During the COVID-19 Pandemic in 2020: Matched Cohort Study. J Am Med Dir Assoc, 23, 923-929.e2. http://doi.org/10.1016/j.jamda.2022.04.003
Gulliford, M. C., Prevost, A. T., Clegg, A., & Rezel-Potts, E. (2022). Mortality of Care Home Residents and Community-Dwelling Controls During the COVID-19 Pandemic in 2020: Matched Cohort Study. J Am Med Dir Assoc, 23, 923-929.e2. http://doi.org/10.1016/j.jamda.2022.04.003
Furby, H., Siadimas, A., Rutten-Jacobs, L., Rodrigues, F. B., & Wild, E. J. (2022). Natural history and burden of Huntington's disease in the UK: A population-based cohort study. Eur J Neurol. http://doi.org/10.1111/ene.15385
James, G., Kim, J., Mellström, C., Ford, K. L., Jenkins, N. C., Tsang, C., et al. (2022). Serum potassium variability as a predictor of clinical outcomes in patients with cardiorenal disease or diabetes: a retrospective UK database study. Clin Kidney J, 15, 758-770. http://doi.org/10.1093/ckj/sfab225
Joseph, R. M., Jack, R. H., Morriss, R., Knaggs, R. D., Butler, D., Hollis, C., et al. (2022). The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records. Bmc Med, 20, 43. http://doi.org/10.1186/s12916-022-02247-x
Iyen, B., Vinogradova, Y., Akyea, R. K., Weng, S., Qureshi, N., & Kai, J. (2022). Ethnic disparities in mortality among overweight or obese adults with newly diagnosed type 2 diabetes: a population-based cohort study. J Endocrinol Invest. http://doi.org/10.1007/s40618-021-01736-9